GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine (Nasdaq: HYPR), ...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® ...
President and CEO Maria Sainz reported first quarter revenue of $2.1 million from six system sales, noting this quarter marks the end of a period where the business relied mainly on U.S. hospital ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Hyperfine (HYPR – Research Report), with a price target of $1.20. Larry Biegelsen has given his Hold rating ...
Hyperfine Inc. ((HYPR)) has held its Q3 earnings call. Read on for the main highlights of the call. Hyperfine Inc. Reports Positive Growth Trajectory Amid Revenue Surge The latest earnings call for ...
Rafael O’Halloran, PhD, and Rob Fasciano, PhD, bring depth and breadth of experience in imaging and Medtech. Rob Fasciano, PhD, joined Hyperfine as Chief Regulatory and Quality Officer, bringing over ...
For the first half of 2025, management now expects revenue in the range of $5 million to $6 million, citing recent U.S. deal losses due to grant funding cancellations at academic institutions. For the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results